Physician profile
Reena Patel
NPI 1457988727
$518.51
in general payments reported to CMS, 2019-2025
10 companies · $269 in 2025
The $269 reported for 2025 was more than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $250 · 2025: $269.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $428 · Education: $90.05.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $428.46 |
| Education | $90.05 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Dentsply Sirona INC | $122.41 | 2024 | Consumable Dentistry |
| Astellas Pharma US INC | $114.11 | 2025 | Veozah |
| Mayne Pharma Commercial LLC | $111.32 | 2025 | |
| Evofem Biosciences, INC. | $37.16 | 2024-2025 | Phexxi, Solosec, Phexx |
| Bayer Healthcare Pharmaceuticals INC. | $32.32 | 2024 | |
| Biogen, INC. | $27.06 | 2025 | Zurzuvae |
| Vertex Pharmaceuticals Incorporated | $25.83 | 2024 | |
| Medtronic, INC. | $19.77 | 2024 | Ligasure |
| Coopersurgical, INC. | $15.37 | 2024 | Paragard T 380a |
| Hologic Sales and Service, LLC | $13.16 | 2024 | Acessa Provu System, Myosure Tissue Removal Device |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Reena Patel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.